221 related articles for article (PubMed ID: 16886677)
21. The first locked side-chain analogues of calcitriol (1alpha,25-dihydroxyvitamin D3) induce vitamin D receptor transcriptional activity.
Pérez-García X; Rumbo A; Larriba MJ; Ordóñez P; Muñoz A; Mouriño A
Org Lett; 2003 Oct; 5(22):4033-6. PubMed ID: 14572242
[TBL] [Abstract][Full Text] [Related]
22. The anti-cancer actions of vitamin D.
Chiang KC; Chen TC
Anticancer Agents Med Chem; 2013 Jan; 13(1):126-39. PubMed ID: 23094926
[TBL] [Abstract][Full Text] [Related]
23. The impact of 1,25(OH)2D3 and its structural analogs on gene expression in cancer cells--a microarray approach.
Kriebitzsch C; Verlinden L; Eelen G; Tan BK; Van Camp M; Bouillon R; Verstuyf A
Anticancer Res; 2009 Sep; 29(9):3471-83. PubMed ID: 19667141
[TBL] [Abstract][Full Text] [Related]
24. Asymmetric catalytic ene-cyclization approach to 2-fluoro-19-nor-1,25-dihydroxyvitamin D(3) A-ring analog with significant transactivation activity.
Mikami K; Ohba S; Ohmura H; Kubodera N; Nakagawa K; Okano T
Chirality; 2001 Jul; 13(7):366-71. PubMed ID: 11400190
[TBL] [Abstract][Full Text] [Related]
25. Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D.
Holt PR; Arber N; Halmos B; Forde K; Kissileff H; McGlynn KA; Moss SF; Kurihara N; Fan K; Yang K; Lipkin M
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):113-9. PubMed ID: 11815408
[TBL] [Abstract][Full Text] [Related]
26. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.
Reddy GS; Robinson M; Wang G; Palmore GT; Gennaro L; Vouros P; De Clercq P; Vandewalle M; Young W; Ling S; Verstuyf A; Bouillon R
Arch Biochem Biophys; 2007 Apr; 460(2):254-61. PubMed ID: 17196157
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic corruption of VDR signalling in malignancy.
Abedin SA; Banwell CM; Colston KW; Carlberg C; Campbell MJ
Anticancer Res; 2006; 26(4A):2557-66. PubMed ID: 16886664
[TBL] [Abstract][Full Text] [Related]
28. The effects of 1,25-dihydroxyvitamin D3 on colon cancer cells depend on RhoA-ROCK-p38MAPK-MSK signaling.
Ordóñez-Morán P; Alvarez-Díaz S; Valle N; Larriba MJ; Bonilla F; Muñoz A
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):355-61. PubMed ID: 20223287
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells.
Alvarez-Díaz S; Valle N; Ferrer-Mayorga G; Lombardía L; Herrera M; Domínguez O; Segura MF; Bonilla F; Hernando E; Muñoz A
Hum Mol Genet; 2012 May; 21(10):2157-65. PubMed ID: 22328083
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D and colon cancer.
Pereira F; Larriba MJ; Muñoz A
Endocr Relat Cancer; 2012 Jun; 19(3):R51-71. PubMed ID: 22383428
[TBL] [Abstract][Full Text] [Related]
31. 19nor-1,25-dihydroxyvitamin D2 specifically induces CYP3A9 in rat intestine more strongly than 1,25-dihydroxyvitamin D3 in vivo and in vitro.
Zierold C; Mings JA; Deluca HF
Mol Pharmacol; 2006 May; 69(5):1740-7. PubMed ID: 16484501
[TBL] [Abstract][Full Text] [Related]
32. C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1.
Astecker N; Bobrovnikova EA; Omdahl JL; Gennaro L; Vouros P; Schuster I; Uskokovic MR; Ishizuka S; Wang G; Reddy GS
Arch Biochem Biophys; 2004 Nov; 431(2):261-70. PubMed ID: 15488475
[TBL] [Abstract][Full Text] [Related]
33. The immunological functions of the vitamin D endocrine system.
Hayes CE; Nashold FE; Spach KM; Pedersen LB
Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):277-300. PubMed ID: 12887108
[TBL] [Abstract][Full Text] [Related]
34. The genes of the coactivator TIF2 and the corepressor SMRT are primary 1alpha,25(OH)2D3 targets.
Dunlop TW; Väisänen S; Frank C; Carlberg C
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):257-60. PubMed ID: 15225781
[TBL] [Abstract][Full Text] [Related]
35. Identification of VDR-responsive gene signatures in breast cancer cells.
Towsend K; Trevino V; Falciani F; Stewart PM; Hewison M; Campbell MJ
Oncology; 2006; 71(1-2):111-23. PubMed ID: 17377416
[TBL] [Abstract][Full Text] [Related]
36. The transcription factors Snail1 and Snail2 repress vitamin D receptor during colon cancer progression.
Larriba MJ; Bonilla F; Muñoz A
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):106-9. PubMed ID: 20138990
[TBL] [Abstract][Full Text] [Related]
37. Recent developments of 19-nor-1,25-dihydroxyvitamin D3 analogues.
Zhang CF; Wan RZ; Liu ZP
ChemMedChem; 2013 Aug; 8(8):1249-60. PubMed ID: 23788554
[TBL] [Abstract][Full Text] [Related]
38. Calcium sensing receptor in human colon carcinoma: interaction with Ca(2+) and 1,25-dihydroxyvitamin D(3).
Chakrabarty S; Wang H; Canaff L; Hendy GN; Appelman H; Varani J
Cancer Res; 2005 Jan; 65(2):493-8. PubMed ID: 15695391
[TBL] [Abstract][Full Text] [Related]
39. 1,25(OH)2D3 attenuates TGF-β1/β2-induced increased migration and invasion via inhibiting epithelial-mesenchymal transition in colon cancer cells.
Chen S; Zhu J; Zuo S; Ma J; Zhang J; Chen G; Wang X; Pan Y; Liu Y; Wang P
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):130-5. PubMed ID: 26523511
[TBL] [Abstract][Full Text] [Related]
40. Calbindin-D28k (CaBP28k) identification and regulation by 1,25-dihydroxyvitamin D3 in human choriocarcinoma cell line JEG-3.
Belkacemi L; Züegel U; Steinmeyer A; Dion JP; Lafond J
Mol Cell Endocrinol; 2005 May; 236(1-2):31-41. PubMed ID: 15922086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
